Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

15.0K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

4.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

6.1K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benzyl-para-di-[5-methyl-4-(n-octylamino) pyrimidin-2(1H)one] as an interferon beta (IFN-β) modulator.

Molecular diversity·2021
Same author

The TLR4 adaptor TRAM controls the phagocytosis of Gram-negative bacteria by interacting with the Rab11-family interacting protein 2.

PLoS pathogens·2019
Same author

Benzyl alcohol induces a reversible fragmentation of the Golgi apparatus and inhibits membrane trafficking between endosomes and the trans-Golgi network.

Experimental cell research·2017
Same author

Molecular constituents of the extracellular matrix in rat liver mounting a hepatic progenitor cell response for tissue repair.

Fibrogenesis & tissue repair·2013
Same author

Retrograde transport of protein toxins through the Golgi apparatus.

Histochemistry and cell biology·2013
Same author

Internalization mechanisms of the epidermal growth factor receptor after activation with different ligands.

PloS one·2013

Related Experiment Video

Updated: Apr 23, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.7K

EGFR signaling patterns are regulated by its different ligands.

Stine Louise Jeppe Knudsen1, Anni Sieu Wai Mac, Lasse Henriksen

  • 1Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen , Denmark .

Growth Factors (Chur, Switzerland)
|September 27, 2014
PubMed
Summary

Different EGF receptor (EGFR) ligands activate specific signaling pathways, with HB-EGF and BTC showing the most potent effects on Akt, PLCγ, and STAT. Ligand binding affinity doesn't fully explain this differential signaling.

Keywords:
BTCEGFEGF receptorHB-EGFTGFαsignaling

More Related Videos

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

1.1K
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

2.3K

Related Experiment Videos

Last Updated: Apr 23, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.7K
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

1.1K
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

2.3K

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Receptor tyrosine kinases

Background:

  • Epidermal Growth Factor Receptor (EGFR) signaling is crucial in cellular processes.
  • Previous research has focused on EGFR activation but less on ligand-specific downstream effects.
  • Understanding differential ligand-mediated signaling is key to comprehending EGFR function.

Purpose of the Study:

  • To investigate how different Epidermal Growth Factor Receptor (EGFR) ligands differentially activate downstream signaling pathways.
  • To identify the most potent ligands for specific EGFR-mediated signaling cascades.
  • To explore the mechanisms underlying ligand-dependent signaling potency.

Main Methods:

  • Utilized HeLa cells to study EGFR activation and downstream signaling.
  • Employed a panel of EGFR ligands to assess pathway activation.
  • Measured the activation of signaling pathways including Akt, PLCγ, STAT, and Erk.
  • Compared ligand binding affinities with observed signaling potencies.

Main Results:

  • A ligand-dependent differential activation of EGFR and downstream pathways (Akt, PLCγ, STAT) was observed.
  • HB-EGF and BTC emerged as the most potent ligands.
  • All tested ligands fully activated Erk signaling at 1 nM.
  • HB-EGF and BTC showed higher potency for Akt, STAT3, and PLCγ activation than explained by binding affinity alone.

Conclusions:

  • EGFR signaling pathway activation is ligand-dependent and cell-specific.
  • Mechanisms beyond binding affinity regulate the potency of HB-EGF and BTC in EGFR signaling.
  • Further research is needed to elucidate these regulatory mechanisms for precise therapeutic targeting.